139 related articles for article (PubMed ID: 27401271)
1. Oxidized Low-Density Lipoprotein-β2-Glycoprotein I Complex But Not Free Oxidized LDL Is Associated With the Presence and Severity of Coronary Artery Disease.
Bliden KP; Chaudhary R; Lopez LR; Damrongwatanasuk R; Guyer K; Gesheff MG; Franzese CJ; Kaza H; Tantry US; Gurbel PA
Am J Cardiol; 2016 Sep; 118(5):673-8. PubMed ID: 27401271
[TBL] [Abstract][Full Text] [Related]
2. Predictive Value of Oxidized Low-Density Lipoprotein/β
Ames PRJ; Di Girolamo G; D'Andrea G; Lopez LR; Gaeta G; Iannaccone L; Maraglione M
Clin Appl Thromb Hemost; 2018 Oct; 24(7):1050-1055. PubMed ID: 29669439
[TBL] [Abstract][Full Text] [Related]
3. Oxidized-LDL/beta(2)-glycoprotein I complexes are associated with disease severity and increased risk for adverse outcomes in patients with acute coronary syndromes.
Greco TP; Conti-Kelly AM; Anthony JR; Greco T; Doyle R; Boisen M; Kojima K; Matsuura E; Lopez LR
Am J Clin Pathol; 2010 May; 133(5):737-43. PubMed ID: 20395520
[TBL] [Abstract][Full Text] [Related]
4. The oxidized low-density lipoprotein/β2-glycoprotein I complex is associated with abdominal obesity in healthy middle-aged men.
Kraml PJ; Syrovátka P; Potočková J; Anděl M
Ann Nutr Metab; 2013; 62(1):7-13. PubMed ID: 23171597
[TBL] [Abstract][Full Text] [Related]
5. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Matsuura E; Kobayashi K; Hurley BL; Lopez LR
Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
[TBL] [Abstract][Full Text] [Related]
6. Proatherogenic oxidized low-density lipoprotein/β2-glycoprotein I complexes in arterial and venous disease.
Berger JS; Rockman CB; Guyer KE; Lopez LR
J Immunol Res; 2014; 2014():234316. PubMed ID: 25405208
[TBL] [Abstract][Full Text] [Related]
7. [OxLDL/β2-glycoprotein I complex as a pro-atherogenic autoantigen. Is atherosclerosis an autoimmune disease?].
Kraml P
Vnitr Lek; 2016; 62(11 Suppl 4):S48-51. PubMed ID: 27921425
[TBL] [Abstract][Full Text] [Related]
8. Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease.
Ndrepepa G; Braun S; von Beckerath N; Mehilli J; Gorchakova O; Vogt W; Schömig A; Kastrati A
Clin Chim Acta; 2005 Oct; 360(1-2):178-86. PubMed ID: 15993392
[TBL] [Abstract][Full Text] [Related]
9. Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis.
Lopez LR; Kobayashi K; Matsunami Y; Matsuura E
Clin Rev Allergy Immunol; 2009 Aug; 37(1):12-9. PubMed ID: 18982458
[TBL] [Abstract][Full Text] [Related]
10. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
Lopez LR; Salazar-Paramo M; Palafox-Sanchez C; Hurley BL; Matsuura E; Garcia-De La Torre I
Lupus; 2006; 15(2):80-6. PubMed ID: 16539278
[TBL] [Abstract][Full Text] [Related]
11. Serum oxLDL-β2GPI complex reflects metabolic syndrome and inflammation in adipose tissue in obese.
Siklova M; Koc M; Rossmeislová L; Kraml P
Int J Obes (Lond); 2018 Mar; 42(3):405-411. PubMed ID: 29081508
[TBL] [Abstract][Full Text] [Related]
12. oxLDL/beta2GPI complex and anti-oxLDL/beta2GPI in SLE: prevalence and correlates.
Bassi N; Zampieri S; Ghirardello A; Tonon M; Zen M; Beggio S; Matsuura E; Doria A
Autoimmunity; 2009 May; 42(4):289-91. PubMed ID: 19811279
[TBL] [Abstract][Full Text] [Related]
13. The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis.
Tabuchi M; Inoue K; Usui-Kataoka H; Kobayashi K; Teramoto M; Takasugi K; Shikata K; Yamamura M; Ando K; Nishida K; Kasahara J; Kume N; Lopez LR; Mitsudo K; Nobuyoshi M; Yasuda T; Kita T; Makino H; Matsuura E
J Lipid Res; 2007 Apr; 48(4):768-81. PubMed ID: 17261875
[TBL] [Abstract][Full Text] [Related]
14. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.
Faviou E; Vourli G; Nounopoulos C; Zachari A; Dionyssiou-Asteriou A
Free Radic Res; 2005 Apr; 39(4):419-29. PubMed ID: 16028367
[TBL] [Abstract][Full Text] [Related]
15. In vivo distribution of single chain variable fragment (scFv) against atherothrombotic oxidized LDL/β
Sasaki T; Kobayashi K; Kita S; Kojima K; Hirano H; Shen L; Takenaka F; Kumon H; Matsuura E
Autoimmun Rev; 2017 Feb; 16(2):159-167. PubMed ID: 27988435
[TBL] [Abstract][Full Text] [Related]
16. Effect of hormone replacement therapy on total serum anti-oxidant potential and oxidized LDL/β2-glycoprotein I complexes in postmenopausal women.
Darabi M; Ani M; Movahedian A; Zarean E; Panjehpour M; Rabbani M
Endocr J; 2010; 57(12):1029-34. PubMed ID: 20978364
[TBL] [Abstract][Full Text] [Related]
17. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
Tsimikas S; Bergmark C; Beyer RW; Patel R; Pattison J; Miller E; Juliano J; Witztum JL
J Am Coll Cardiol; 2003 Feb; 41(3):360-70. PubMed ID: 12575961
[TBL] [Abstract][Full Text] [Related]
18. [The oxLDL/β2GPI/β2GPI-Ab complex promotes the migration and the expression of inflammatory cytokines in human umbilical vein endothelial cells].
Cai Q; Zhou H; Zhang G; He C; Zhu X; Wang X; Ouyang H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):865-869. PubMed ID: 28712390
[TBL] [Abstract][Full Text] [Related]
19. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis.
Matsuura E; Kobayashi K; Inoue K; Lopez LR; Shoenfeld Y
Lupus; 2005; 14(9):736-41. PubMed ID: 16218478
[TBL] [Abstract][Full Text] [Related]
20. [The oxLDL/β2GPI/anti-β2GPI antibody complex promotes A7r5 chemotaxis, migration and lipid accumulation].
Ouyang H; Zhou H; He C; Zhang G; Chen Y; Wang T; Wang X; Zhang P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Dec; 33(12):1622-1627. PubMed ID: 29382421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
